Cargando…

Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation

Detalles Bibliográficos
Autores principales: Roy, V, Stewart, A K, Bergsagel, P L, Dispenzieri, A, Laumann, K, Allred, J, Lacy, M Q, Fonseca, R, Reeder, C B, Kumar, S, Rivera, C E, Gertz, M A, Buadi, F K, Hayman, S R, Rajkumar, S V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382664/
https://www.ncbi.nlm.nih.gov/pubmed/25794130
http://dx.doi.org/10.1038/bcj.2015.23
_version_ 1782364617252536320
author Roy, V
Stewart, A K
Bergsagel, P L
Dispenzieri, A
Laumann, K
Allred, J
Lacy, M Q
Fonseca, R
Reeder, C B
Kumar, S
Rivera, C E
Gertz, M A
Buadi, F K
Hayman, S R
Rajkumar, S V
author_facet Roy, V
Stewart, A K
Bergsagel, P L
Dispenzieri, A
Laumann, K
Allred, J
Lacy, M Q
Fonseca, R
Reeder, C B
Kumar, S
Rivera, C E
Gertz, M A
Buadi, F K
Hayman, S R
Rajkumar, S V
author_sort Roy, V
collection PubMed
description
format Online
Article
Text
id pubmed-4382664
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-43826642015-04-07 Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation Roy, V Stewart, A K Bergsagel, P L Dispenzieri, A Laumann, K Allred, J Lacy, M Q Fonseca, R Reeder, C B Kumar, S Rivera, C E Gertz, M A Buadi, F K Hayman, S R Rajkumar, S V Blood Cancer J Letter to the Editor Nature Publishing Group 2015-03 2015-03-20 /pmc/articles/PMC4382664/ /pubmed/25794130 http://dx.doi.org/10.1038/bcj.2015.23 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Roy, V
Stewart, A K
Bergsagel, P L
Dispenzieri, A
Laumann, K
Allred, J
Lacy, M Q
Fonseca, R
Reeder, C B
Kumar, S
Rivera, C E
Gertz, M A
Buadi, F K
Hayman, S R
Rajkumar, S V
Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation
title Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation
title_full Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation
title_fullStr Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation
title_full_unstemmed Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation
title_short Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation
title_sort phase i/ii study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382664/
https://www.ncbi.nlm.nih.gov/pubmed/25794130
http://dx.doi.org/10.1038/bcj.2015.23
work_keys_str_mv AT royv phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation
AT stewartak phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation
AT bergsagelpl phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation
AT dispenzieria phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation
AT laumannk phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation
AT allredj phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation
AT lacymq phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation
AT fonsecar phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation
AT reedercb phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation
AT kumars phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation
AT riverace phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation
AT gertzma phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation
AT buadifk phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation
AT haymansr phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation
AT rajkumarsv phaseiiistudyofmelphalanprednisoneandlenalidomidecombinationforpatientswithnewlydiagnosedmultiplemyelomawhoarenotcandidatesforstemcelltransplantation